Results 101 to 110 of about 22,846,314 (192)

[No-reflow phenomenon in the practice of an endovascular surgeon].

Vestnik rentgenologii i radiologii, 2014
No-reflow phenomenon is a complication of percutaneous coronary intervention and is the absence of distal coronary bed filling. The main cause of this phenomenon is distal embolism of the coronary artery by atheromatous and thrombotic masses. The paper gives different classifications for evaluation of myocardial and coronary reperfusion.
A. M. Gerasimov, A. S. Tereshchenko, E. V. Merkulov, A. N. Samko   +3 more
openaire   +2 more sources

Effects of streptokinase on reflow in rescue percutaneous coronary intervention

ARYA Atherosclerosis, 2013
BACKGROUND: Primary percutaneous coronary intervention (PPCI) is the preferred treatment method for ST elevation myocardial infarction (STEMI). However, the required equipments are not available in all hospitals.
Masoud Sanatkar, Hassan Shemirani, Hamid Sanei, Masoud Pourmoghaddas, Katayoun Rabiei   +4 more
doaj  

The predictors of no-reflow phenomenon after primary angioplasty for acute myocardial infarction [PDF]

, 2016
Background: No-reflow phenomenon is a serious complication of primary Percutaneous Coronary Intervention (PCI), which may increase the risk of progressive myocardial damage, profound left ventricular dysfunction, and death.
Shahsavari, H., Sanati, H., Mehr, A.Z., Kiani, R., Shakerian, F., Firouzi, A., Aeinfar, K.   +6 more
core  

Hyperglycemia as a predictor for no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction

Clinical Innovations in Health Research-HJM
Introduction: The no-reflow phenomenon (NRP) is a complication associated with in-hospital mortality in patients undergoing percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).
Oswaldo Aldana-Varela, Iván R. Flores-Gómez, Araceli Villanueva-Balandrán, Ricardo J. López-Castellanos, José L. Victoria-Campos, Ma. de Lourdes Santiago-González   +5 more
doaj  

Plasma metabolomic signatures of the no-reflow phenomenon in stroke patients following thrombectomy. [PDF]

Front Neurol
Li X, Chen X, Pan H, Wu J, Mi S, Jiang Y, Zhou L, Wang Y, Wu M, Hou X, Zhou Z.   +10 more
europepmc   +1 more source

The role of non-coding RNAs in the coronary no-reflow phenomenon: a systematic review. [PDF]

Mol Biol Rep
Sukiennik A, Tomkiel D, Procyk G.
europepmc   +1 more source

Distal Versus Proximal Intracoronary Drug Delivery for the Treatment of the No-Reflow Phenomenon During Percutaneous Coronary Intervention. [PDF]

J Clin Med
Savur U, Keskin B, Koc I, Khidolda Y, Dursun A, Akhundova A, Hakgor A, Gunes HM, Boztosun B.   +8 more
europepmc   +1 more source

Predictive Ability of the CHA2DS2-VA Score for No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI. [PDF]

Clin Cardiol
Sun Y, Ren J, Wang W, Wang C, Liu M, Liu J, Qi X, Yao H.   +7 more
europepmc   +1 more source

An <i>in silico</i> bioinformatics framework for prioritizing candidate genes in the coronary no-reflow phenomenon. [PDF]

Glob Cardiol Sci Pract
Rahman FA, Suryono S, Maulana AS, Wulandari P.   +3 more
europepmc   +1 more source

The no-reflow phenomenon: current treatment and prevention strategies

The no-reflow phenomenon remains a significant challenge in the management of myocardial infarction, despite advances in reperfusion therapy, including widespread use of primary percutaneous coronary intervention (PCI).
S. V. Dil, E. V. Vyshlov, M. A. Kercheva, L. N. Maslov, V. V. Ryabov   +4 more
core   +1 more source